REGISTERED NUMBER: 12729709 (England and Wales)

Unaudited Financial Statements

for the Period 1 August 2024 to 30 June 2025

for

Dr Julia Ltd

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr J Sevi

Mr A Sevi

REGISTERED OFFICE:

305

Harrogate Road

Leeds

West Yorkshire

LS17 6PA

REGISTERED NUMBER:

12729709 (England and Wales)

ACCOUNTANTS:

Wild & Co Chartered Accountants

Windsor House

Cornwall Road

Harrogate

HG1 2PW

FIXED ASSETS

Tangible assets

4

3,452

-

CURRENT ASSETS

Debtors

4,556

2,202

Cash at bank

54,031

26,264

58,587

28,466

CREDITORS

Amounts falling due within one year

18,368

7,770

NET CURRENT ASSETS

40,219

20,696

TOTAL ASSETS LESS CURRENT LIABILITIES

43,671

20,696

PROVISIONS FOR LIABILITIES

5

863

-

NET ASSETS

42,808

20,696

CAPITAL AND RESERVES

Called up share capital

6

100

100

Retained earnings

42,708

20,596

SHAREHOLDERS' FUNDS

42,808

20,696

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the period ended 30 June 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2025 and were signed on its behalf by:

Dr J Sevi - Director

1.	STATUTORY INFORMATION

Dr Julia Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

Straight line over 3 years

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

Additions

4,439

At 30 June 2025

4,439

DEPRECIATION

Charge for period

987

At 30 June 2025

987

NET BOOK VALUE

At 30 June 2025

3,452

5.	PROVISIONS FOR LIABILITIES

30.6.25

31.7.24

£

£

Deferred tax

863

-

Deferred

tax

£

Provided during period

863

Balance at 30 June 2025

863

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.25

31.7.24

value:

£

£

100

Ordinary

£1

100

100

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 30 June 2025 and the year ended 31 July 2024:

30.6.25

31.7.24

£

£

Dr J Sevi

Balance outstanding at start of period

(419

)

(107

)

Amounts advanced

(33,262

)

(312

)

Amounts repaid

33,681

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of period

-

(419

)

8.	RELATED PARTY DISCLOSURES

At the year end, the company owed Aesthetic Health Limited, £904. Dr J Sevi is a director of this company. The loan is interest free.

At the year end, Brain Centre Ltd owed the company £214. Mr A Sevi is a director of this company. The loan is interest free.

At the year end, Longlife Ltd owed the company £94. Mr A Sevi is a director of this company. The loan is interest free.